Geron Corporation - Common Stock (NQ:GERN)

0.9776 -0.1024 (-9.48%)

Delayed Quote Updated: 11:15 AM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Geron Corporation - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Geron Announces September Investor Conference Presentation Webcasts

September 01, 2021

From Geron Corporation

Via Business Wire

Here's What Investors Need From Geron ↗

August 28, 2021

It could be a while before Geron has a big catalyst.

Via The Motley Fool

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 19, 2021

From Geron Corporation

Via Business Wire

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business ↗

August 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...

Via Benzinga

Geron (GERN) Q2 2021 Earnings Call Transcript ↗

August 17, 2021

GERN earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: Geron Q2 Earnings ↗

August 16, 2021

Shares of Geron (NASDAQ:GERN) rose 2.5% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 50.00% over the past year to...

Via Benzinga

Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023

August 16, 2021

From Geron Corporation

Via Business Wire

August 13, 2021

Via FinancialNewsMedia

Earnings Scheduled For August 16, 2021 ↗

August 16, 2021

Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to...

Via Benzinga

30 Stocks Moving in Friday's Pre-Market Session ↗

August 13, 2021

Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 32.9% to $0.839 in pre-market trading after the company reported better-than-expected Q2 sales. The company said it continues to...

Via Benzinga

Geron to Announce Second Quarter 2021 Financial Results on August 16, 2021

August 05, 2021

From Geron Corporation

Via Business Wire

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 22, 2021

From Geron Corporation

Via Business Wire

Return On Capital Employed Overview: Geron ↗

June 24, 2021

During Q1, Geron's (NASDAQ:GERN) reported sales totaled $137.00 thousand. Despite a 22.3% in earnings, the company posted a loss of $28.45 million. Geron collected $50.00 thousand...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 21, 2021

Gainers MediciNova (NASDAQ:MNOV) shares moved upwards by 50.79% to $5.67 during Monday's pre-market session. The market value of their outstanding shares is at $276.5...

Via Benzinga

58 Biggest Movers From Friday ↗

June 21, 2021

Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc....

Via Benzinga

Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; CAI International Shares Spike Higher ↗

June 18, 2021

Toward the end of trading Friday, the Dow traded down 1.27% to 33,394.86 while the NASDAQ fell 0.92% to 14,031.05. The S&P also fell, dropping 1.03% to 4,178.31. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 18, 2021

Gainers Geron (NASDAQ:GERN) shares increased by 53.19% to $2.16 during Friday's regular session. As of 12:33 EST, Geron's stock is trading at a volume of 179.2...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises Over 1%; Orphazyme Shares Plunge ↗

June 18, 2021

Midway through trading Friday, the Dow traded down 1.13% to 33,440.28 while the NASDAQ fell 0.74% to 14,056.31. The S&P also fell, dropping 0.92% to 4,183.07. The U.S. has the...

Via Benzinga

Topics Stocks

32 Stocks Moving In Friday's Mid-Day Session ↗

June 18, 2021

Gainers CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Sykes Enterprises,...

Via Benzinga

Why Geron Stock Is Soaring Today ↗

June 18, 2021

Investors are cheering the company's encouraging phase 2 data.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 18, 2021

Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) stock rose 21.47% to $5.26 during Friday's pre-market session. The company's market cap stands at $68.5 million....

Via Benzinga

The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs ↗

June 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

28 Stocks Moving in Friday's Pre-Market Session ↗

June 18, 2021

Gainers CAI International, Inc. (NYSE: CAI) rose 45.1% to $55.35 in pre-market trading after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Geron...

Via Benzinga

Geron Stock Trading Is Higher On Reinforcing Imetelstat's Approach For Myelofibrosis Treatment, With Data Publication In Journal ↗

June 18, 2021

Geron Corporation (NASDAQ: GERN) stock is trading higher during the premarket in reaction to data publication from the IMbark Phase 2 trial of imetelstat for...

Via Benzinga

Geron Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology

June 17, 2021

From Geron Corporation

Via Business Wire

Geron Reports Two Presentations at Virtual European Hematology Association Annual Congress

June 14, 2021

From Geron Corporation

Via Business Wire

Geron: Return On Capital Employed Insights ↗

June 08, 2021

During Q1, Geron's (NASDAQ:GERN) reported sales totaled $137.00 thousand. Despite a 22.3% in earnings, the company posted a loss of $28.45 million. In Q4, Geron brought in $50.00...

Via Benzinga

Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress

May 12, 2021

From Geron Corporation

Via Business Wire

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗

May 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.